Ionis Pharmaceuticals SG&A Expense (Quarterly) Analysis

Ionis Pharmaceuticals Inc (IONS)

39.47 -0.69 (-1.72%) USD | NASDAQ | May 09, 16:00

39.45 -0.02 (-0.05%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1991. Upgrade now.

Date	Value
March 31, 2024	52.64M
December 31, 2023	71.00M
September 30, 2023	70.00M
June 30, 2023	46.10M
March 31, 2023	45.52M
December 31, 2022	47.90M
September 30, 2022	34.40M
June 30, 2022	33.80M
March 31, 2022	34.13M
December 31, 2021	38.60M
September 30, 2021	30.10M
June 30, 2021	45.10M
March 31, 2021	57.10M
December 31, 2020	116.70M
September 30, 2020	68.40M
June 30, 2020	72.02M
March 31, 2020	75.00M
December 31, 2019	83.28M
September 30, 2019	60.04M
June 30, 2019	75.11M
March 31, 2019	68.22M
December 31, 2018	66.06M
September 30, 2018	68.71M
June 30, 2018	66.20M
March 31, 2018	43.65M

Date	Value
December 31, 2017	45.71M
September 30, 2017	26.79M
June 30, 2017	22.32M
March 31, 2017	13.68M
December 31, 2016	18.04M
September 30, 2016	10.19M
June 30, 2016	9.824M
March 31, 2016	10.56M
December 31, 2015	13.18M
September 30, 2015	8.751M
June 30, 2015	7.775M
March 31, 2015	7.466M
December 31, 2014	6.827M
September 30, 2014	4.47M
June 30, 2014	4.462M
March 31, 2014	4.38M
December 31, 2013	4.677M
September 30, 2013	3.43M
June 30, 2013	3.389M
March 31, 2013	3.423M
December 31, 2012	3.234M
September 30, 2012	3.096M
June 30, 2012	3.209M
March 31, 2012	2.976M
December 31, 2011	3.80M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

30.10M

Minimum

Sep 2021

116.70M

Maximum

Dec 2020

57.85M

Average

54.87M

Median

SG&A Expense (Quarterly) Benchmarks